This topic contains a solution. Click here to go to the answer

Author Question: The condition bilateral contusion of ovaries (initial encounter) is assigned ICD-10-CM code(s) ... (Read 68 times)

bobthebuilder

  • Hero Member
  • *****
  • Posts: 567
The condition bilateral contusion of ovaries (initial encounter) is assigned ICD-10-CM code(s) __________.
 a. S37.401A, S37.401A
  b. S37.402A
 c. S37.422A
 d. S37.499A

Question 2

When a bilateral ICD-10-CM code is not provided and the condition is bilateral, __________.
 a. assign separate codes for both the left and right side
  b. contact the cooperating parties for official guidelines
  c. generate a physician query to determine the code
 d. use CPT modifier -50 with the unspecified side code



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jevvish

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

c

Answer to Question 2

a




bobthebuilder

  • Member
  • Posts: 567
Reply 2 on: Jun 27, 2018
Wow, this really help


ryansturges

  • Member
  • Posts: 338
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library